POINT Biopharma Global IncEigentümerstruktur
| Preis (2024-01-25) | 52W Hoch | 52W Tief |
| 0 USD | 14,35 USD | 6,57 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 14,56 USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 106.569.000 | 3,32 | 1,41 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name POINT Biopharma Global Inc
Mitarbeiter 129
Handelsplatz NASDAQ
Ticker Symbol PNT
IPO Datum 2020-07-08
Adresse 4850 West 78th Street, Indianapolis, IN, United States, 46268
Webseite https://www.pointbiopharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Allan Charles Silber | Exec. Chairman |
| 2 | Dr. Joe A. McCann Ph.D. | CEO & Director |
| 3 | Dr. Neil E. Fleshner FRCSC, M.D., M.PH | Chief Medical Officer & Director |
| 4 | Ms. Jessica D. Jensen M.P.H., MPH | Exec. VP of Clinical Devel. |
| 5 | Mr. Bill Demers B.B.A., F.C.A., FCPA | Chief Financial Officer |
| 6 | Ms. Justyna Kelly M.Sc. | Chief Operating Officer |
| 7 | Ms. Donna Husack B.A. | VP of HR |
| 8 | Mr. Ari Shomair | VP of Corp. Affairs & Chief of Staff |
| 9 | Dr. Myra Rosario Herle Ph.D., R.Ph. | Exec. VP of Regulatory Affairs |
| 10 | Dr. Matthew P. Vincent J.D., Ph.D. | Sr. VP of Bus. Devel. |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corporation | 0,00% | 0,00 Mio. USD |
| 5 | Boxer Capital LLC | 0,00% | 0,00 Mio. USD |
| 6 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 7 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Partner Fund Management LP | 0,00% | 0,00 Mio. USD |
| 9 | Johnson & Johnson | 0,00% | 0,00 Mio. USD |
| 10 | Nuveen Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 12 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 13 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 14 | Gluskin Sheff & Associates Inc | 0,00% | 0,00 Mio. USD |
| 15 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 16 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 17 | Nantahala Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Polar Asset Management Partners | 0,00% | 0,00 Mio. USD |
| 19 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 20 | Bank of America Corp | 0,00% | 0,00 Mio. USD |